https://biotechmorning.com/news/trump-administration-psychedelics-fda-vouchers Biotech Morning en 2026-05-04T14:07:15.519Z The White House Just Went Pro-Psychedelics. Nobody Saw It Coming. https://biotechmorning.com/news/intellia-one-shot-crispr-gene-editing-hae Biotech Morning en 2026-05-04T14:06:36.003Z One Shot to Silence a Disease Forever https://biotechmorning.com/news/ucb-acquires-candid-therapeutics-2-billion Biotech Morning en 2026-05-04T14:05:53.213Z UCB Just Dropped $2 Billion on a Company That's Barely a Year Old https://biotechmorning.com/news/celcuity-gedatolisib-beats-novartis-piqray-breast-cancer Biotech Morning en 2026-05-04T14:05:12.040Z The $10 Million Drug That Just Humbled a Pharma Giant https://biotechmorning.com/news/esperion-goes-private-archimed-deal Biotech Morning en 2026-05-03T14:07:20.953Z Why Esperion Just Ghosted Wall Street https://biotechmorning.com/news/gilead-walks-away-arcus-oncology-alliance Biotech Morning en 2026-05-03T14:06:46.063Z Gilead Just Walked Away From a $1 Billion Bet on Cancer https://biotechmorning.com/news/merck-billion-dollar-google-cloud-ai-deal-2 Biotech Morning en 2026-05-03T14:06:02.149Z Merck Just Bet $1 Billion That Google Can Fix Drug Discovery